Df. Brown et al., NEUROPATHOLOGIC EVIDENCE THAT THE LEWY BODY VARIANT OF ALZHEIMER-DISEASE REPRESENTS COEXISTENCE OF ALZHEIMER-DISEASE AND IDIOPATHIC PARKINSON-DISEASE, Journal of neuropathology and experimental neurology, 57(1), 1998, pp. 39-46
We undertook this study to investigate the neuropathologic relationshi
ps among Alzheimer disease (AD), idiopathic Parkinson disease (PD), an
d the Lewy body variant of AD (AD/LBV). We retrieved 30 autopsy cases
in which Lewy bodies (LB) had been identified in the substantia nigra
(SN) in routine hematoxylin-eosin-stained sections. Twenty-two of the
cases had a primary clinical diagnosis of dementia and neuropathologic
changes of AD; 12 of these demented patients also had clinical parkin
sonism. Eight cases had clinical and neuropathologic evidence of PD wi
th minimal or no AD neuropathology, though 6 had clinical dementia. Co
ntrols consisted of 6 cases of AD without SN LB by hematoxylin-eosin,
and 5 neurologically normal aged controls. Paraffin sections of SN, su
perior temporal gyrus, and cingulate gyrus from each case were immunos
tained with rabbit anti-ubiquitin antiserum, randomized, and analyzed
individually by light microscopy, and the density of LB-like profiles
in each section were graded. None of 5 nondemented aged controls showe
d any neocortical LB, even though 2 had significant numbers of inciden
tal SN LB by ubiquitin immunostaining. Of 6 AD cases without SN LB by
hematoxylin-eosin, 3 had rare SN LB on ubiquitin stain, 1 of which sho
wed rare neocortical Lewy-like profiles. Seven of 8 PD cases showed ne
ocortical LB, including the 6 with dementia. Twenty-one of 22 AD cases
with SN LB showed ubiquitin-immunoreactive Lewy-like bodies in the ne
ocortex that were statistically significantly greater in number than i
n either pure PD or pure AD cases. The frequent occurrence of LB in th
e neocortex in PD alone suggests that AD/LBV likely represents mixed A
D/PD. However, AD neuropathology may favor or promote the formation of
neocortical LB in patients who go on to develop mixed AD/PD pathology
.